BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26410743)

  • 21. Abnormal Subcortical Volumes and Cortical Thickness in Parkinson's Disease with Impulse Control Disorders.
    Prasad S; Reddam VR; Stezin A; Yadav R; Saini J; Pal PK
    Ann Indian Acad Neurol; 2019; 22(4):426-431. PubMed ID: 31736563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.
    Ray N; Strafella AP
    Clin EEG Neurosci; 2010 Apr; 41(2):87-93. PubMed ID: 20521491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.
    Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G
    Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences of gray matter morphology in cortico-limbic-striatal neural system in major depressive disorder.
    Kong L; Chen K; Womer F; Jiang W; Luo X; Driesen N; Liu J; Blumberg H; Tang Y; Xu K; Wang F
    J Psychiatr Res; 2013 Jun; 47(6):733-9. PubMed ID: 23453566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural correlates of risky decision making in Parkinson's disease patients with impulse control disorders.
    Ruitenberg MFL; Koppelmans V; Wu T; Averbeck BB; Chou KL; Seidler RD
    Exp Brain Res; 2022 Sep; 240(9):2241-2253. PubMed ID: 35852565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Kim J; Paz-Alonso PM; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Strafella AP; Rodriguez-Oroz MC
    Parkinsonism Relat Disord; 2020 Jan; 70():74-81. PubMed ID: 31881521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms.
    Surdhar I; Gee M; Bouchard T; Coupland N; Malykhin N; Camicioli R
    Parkinsonism Relat Disord; 2012 Aug; 18(7):809-13. PubMed ID: 22652466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problematic Internet use in Parkinson's disease.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Lees A; Piccini P
    Parkinsonism Relat Disord; 2014 May; 20(5):482-7. PubMed ID: 24582704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unmasking neurobiological commonalities between addictive disorders and impulse control disorders in Parkinson's disease.
    Ramdave S; Dawson A; Carter A; Dissanayaka NNW
    Brain Imaging Behav; 2020 Dec; 14(6):2785-2798. PubMed ID: 30707344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiety in Parkinson's disease is associated with reduced structural covariance of the striatum.
    Oosterwijk CS; Vriend C; Berendse HW; van der Werf YD; van den Heuvel OA
    J Affect Disord; 2018 Nov; 240():113-120. PubMed ID: 30059937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Tessitore A; De Micco R; Giordano A; di Nardo F; Caiazzo G; Siciliano M; De Stefano M; Russo A; Esposito F; Tedeschi G
    Mov Disord; 2017 Dec; 32(12):1710-1719. PubMed ID: 28949049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impulse control disorders in Parkinson's disease versus in healthy controls: A different predictive model.
    Izzo VA; Donati MA; Torre E; Ramat S; Primi C
    J Neuropsychol; 2020 Jun; 14(2):318-332. PubMed ID: 31423741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.
    Carriere N; Besson P; Dujardin K; Duhamel A; Defebvre L; Delmaire C; Devos D
    Mov Disord; 2014 Jun; 29(7):897-903. PubMed ID: 24817690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.
    Liu B; Luo W; Mo Y; Wei C; Tao R; Han M
    Neurosci Lett; 2019 Aug; 707():134313. PubMed ID: 31167116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing.
    Meyer GM; Spay C; Laurencin C; Ballanger B; Sescousse G; Boulinguez P
    Neurosci Biobehav Rev; 2019 Mar; 98():164-176. PubMed ID: 30639672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience.
    Bugalho P; Oliveira-Maia AJ
    Behav Neurol; 2013 Jan; 27(4):547-57. PubMed ID: 23242359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.